Pirker R - Search Results

1

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.

Heller G, Geradts J, Ziegler B, Newsham I, Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer W, Depisch D, Pirker R, Zielinski CC, Zöchbauer-Müller S. Heller G, et al. Among authors: pirker r. Breast Cancer Res Treat. 2007 Jul;103(3):283-91. doi: 10.1007/s10549-006-9377-7. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260099

2

MDR1 gene expression and prognostic factors in primary breast carcinomas.

Wallner J, Depisch D, Hopfner M, Haider K, Spona J, Ludwig H, Pirker R. Wallner J, et al. Among authors: pirker r. Eur J Cancer. 1991;27(11):1352-5. doi: 10.1016/0277-5379(91)90008-2. Eur J Cancer. 1991. PMID: 1835847

3

Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines.

Berger W, Elbling L, Minai-Pour M, Vetterlein M, Pirker R, Kokoschka EM, Micksche M. Berger W, et al. Among authors: pirker r. Int J Cancer. 1994 Dec 1;59(5):717-23. doi: 10.1002/ijc.2910590522. Int J Cancer. 1994. PMID: 7960246

4

MDR1 gene expression in primary colorectal carcinomas.

Pirker R, Wallner J, Gsur A, Götzl M, Zöchbauer S, Scheithauer W, Depisch D. Pirker R, et al. Br J Cancer. 1993 Oct;68(4):691-4. doi: 10.1038/bjc.1993.411. Br J Cancer. 1993. PMID: 8398695 Free PMC article.

5

Effective second line chemotherapy of advanced breast cancer with navelbine and mitomycin C.

Scheithauer W, Kornek G, Haider K, Kwasny W, Schenk T, Pirker R, Depisch D. Scheithauer W, et al. Among authors: pirker r. Breast Cancer Res Treat. 1993;26(1):49-53. doi: 10.1007/BF00682699. Breast Cancer Res Treat. 1993. PMID: 8400323 Clinical Trial.

6

MDR1 gene expression and its clinical relevance in primary gastric carcinomas.

Wallner J, Depisch D, Gsur A, Götzl M, Haider K, Pirker R. Wallner J, et al. Among authors: pirker r. Cancer. 1993 Feb 1;71(3):667-71. doi: 10.1002/1097-0142(19930201)71:3<667::aid-cncr2820710303>3.0.co;2-6. Cancer. 1993. PMID: 8431845

7

Clinical relevance of drug resistance genes in malignant disease.

Filipits M, Suchomel RW, Zöchbauer S, Malayeri R, Pirker R. Filipits M, et al. Among authors: pirker r. Leukemia. 1996 Jul;10 Suppl 3:S10-S17. Leukemia. 1996. PMID: 8656694 Review.

8

Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.

Fillpits M, Suchomel RW, Dekan G, Stiglbauer W, Haider K, Depisch D, Pirker R. Fillpits M, et al. Among authors: pirker r. Br J Cancer. 1997;75(2):208-12. doi: 10.1038/bjc.1997.35. Br J Cancer. 1997. PMID: 9010028 Free PMC article.

9

Multidrug resistance in leukemias and its reversal.

Malayeri R, Filipits M, Suchomel RW, Zöchbauer S, Lechner K, Pirker R. Malayeri R, et al. Among authors: pirker r. Leuk Lymphoma. 1996 Nov;23(5-6):451-8. doi: 10.3109/10428199609054853. Leuk Lymphoma. 1996. PMID: 9031075 Review.

10

Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status.

Filipits M, Suchomel RW, Lechner K, Pirker R. Filipits M, et al. Among authors: pirker r. Leukemia. 1997 Jul;11(7):1073-7. doi: 10.1038/sj.leu.2400655. Leukemia. 1997. PMID: 9204994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters